PolyPid Ltd

PYPD

Company Profile

  • Business description

    PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

  • Contact

    18 Hasivim Street
    P.O Box 7126
    Petach Tikva495376
    ISR

    T: +972 747195700

    https://www.polypid.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    61

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,741.4016.50-0.19%
CAC 407,553.45102.67-1.34%
DAX 4023,057.38260.43-1.12%
Dow JONES (US)42,171.6644.14-0.10%
FTSE 1008,791.8051.67-0.58%
HKSE23,237.74472.95-1.99%
NASDAQ19,546.2725.180.13%
Nikkei 22538,488.34396.81-1.02%
NZX 50 Index12,569.0558.27-0.46%
S&P 5005,980.871.85-0.03%
S&P/ASX 2008,523.707.50-0.09%
SSE Composite Index3,362.1126.70-0.79%

Market Movers